XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Series B Preferred Stock
Series C Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Series B Preferred Stock
Accumulated Deficit
Series C Preferred Stock
Accumulated Other Comprehensive Income
Balance (in shares) at Dec. 31, 2020       8,000 11,000 112,929          
Beginning balance at Dec. 31, 2020 $ 2,524,802     $ 80 $ 110 $ 1,129 $ 3,851,517 $ (1,405,327)     $ 77,293
Increase (Decrease) in Stockholders' Equity                      
Net (loss)/income 85,522             85,522      
Issuance of stock, net of expenses (in shares)           139          
Issuance of common stock, net of expenses 382         $ 1 381        
Repurchase of shares of common stock (in shares) [1]           (1,540)          
Repurchase of shares of common stock [1] (25,136)         $ (15) (25,121)        
Equity based compensation expense 1,686           1,686        
Change in accrued dividends attributable to stock-based awards 489           489        
Dividends declared on common stock [2] (33,521)             (33,521)      
Dividends declared on preferred stock (8,219) $ (3,750) $ (4,468)           $ (3,750) $ (4,468)  
Dividends attributable to dividend equivalents (120)             (120)      
Change in unrealized gains on securities, net (3,855)                   (3,855)
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk 235                   235
Balance (in shares) at Mar. 31, 2021       8,000 11,000 111,528          
Ending balance at Mar. 31, 2021 2,542,266     $ 80 $ 110 $ 1,115 3,828,952 (1,361,664)     73,673
Balance (in shares) at Dec. 31, 2021       8,000 11,000 108,138          
Beginning balance at Dec. 31, 2021 2,542,848     $ 80 $ 110 $ 1,082 3,775,482 (1,279,484)     45,578
Increase (Decrease) in Stockholders' Equity                      
Net (loss)/income (82,906)             (82,906)      
Issuance of stock, net of expenses (in shares)           150          
Issuance of common stock, net of expenses 486         $ 1 485        
Repurchase of shares of common stock (in shares) [3]           (3,252)          
Repurchase of shares of common stock [3] (55,742)         $ (33) (55,709)        
Equity based compensation expense 2,642           2,642        
Change in accrued dividends attributable to stock-based awards (76)           74 (150)      
Dividends declared on common stock [4] (46,215)             (46,215)      
Dividends declared on preferred stock (8,219) $ (3,750) $ (4,469)           $ (3,750) $ (4,469)  
Dividends attributable to dividend equivalents (141)             (141)      
Change in unrealized gains on securities, net (4,977)                   (4,977)
Changes in fair value of financing agreements at fair value due to changes in instrument-specific credit risk 1,255                   1,255
Balance (in shares) at Mar. 31, 2022       8,000 11,000 105,036          
Ending balance at Mar. 31, 2022 $ 2,348,955     $ 80 $ 110 $ 1,050 $ 3,722,974 $ (1,417,115)     $ 41,856
[1] For the three months ended March 31, 2021, includes approximately $799,000 (53,281 shares) surrendered for tax purposes related to equity-based compensation awards
[2] Based on the number of shares held by stockholders at the record date and before giving effect to the Company’s 1 for 4 reverse stock split effected on April 4, 2022.
[3] For the three months ended March 31, 2022 includes approximately $1.0 million (56,690 shares) surrendered for tax purposes related to equity-based compensation awards.
[4] Based on the number of shares held by stockholders at the record date and before giving effect to the Company’s 1 for 4 reverse stock split effected on April 4, 2022.